US Stock MarketDetailed Quotes

RSLS ReShape Lifesciences

Watchlist
  • 0.1681
  • -0.0064-3.67%
Close Aug 27 16:00 ET
4.94MMarket Cap0.41P/E (TTM)

ReShape Lifesciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ReShape Lifesciences Q2 2024 Earnings Date

Currency：USDAug 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
1.97M
--
-12.82%
EPS
--
-0.06
--
+94.44%
Analyst Rating
Hold

Jul 17, 2024

ReShape Lifesciences Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
May 15, 20242024/Q11.944M / 2.104M--
--2023/Q41.982M / 2.208M--
Nov 8, 20232023/Q32.155M / 2.400M--
Aug 7, 20232023/Q22.254M / 2.610M--
May 15, 20232023/Q12.287M / 2.513M--
DatePeriodRevenue/EstimateEarnings Call
May 15, 20242024/Q11.944M / 2.104M--
--2023/Q41.982M / 2.208M--
Nov 8, 20232023/Q32.155M / 2.400M--
Aug 7, 20232023/Q22.254M / 2.610M--
May 15, 20232023/Q12.287M / 2.513M--

Unlock Free Earnings Estimates

ReShape Lifesciences Earnings Reports

  • ReShape Lifesciences | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:36 ET

  • ReShape Lifesciences | 10-Q: Q1 2024 Earnings Report

    May 15 16:56 ET

  • ReShape Lifesciences | 10-K: FY2023 Annual Report

    Apr 1 17:25 ET

  • ReShape Lifesciences | 10-Q: Q3 2023 Earnings Report

    Nov 8, 2023 18:19 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 17, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg